{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:15:16Z","timestamp":1792077316650,"version":"4.4.0"},"reference-count":14,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2026,9]]},"abstract":"\n Objectives<\/jats:title>\n To evaluate current adoption of guidelines for low\u2010 and intermediate\u2010risk non\u2013muscle\u2010invasive bladder cancer (NMIBC) in the UK and to assess clinicians' ability to apply their chosen guideline consistently to real\u2010world clinical scenarios.<\/jats:p>\n <\/jats:sec>\n \n Patients and Methods<\/jats:title>\n This study is a cross\u2010sectional survey distributed to clinicians involved in the management of NMIBC in the UK. Respondents reported their unit\u2010level and personal guideline adoption (National Institute for Health and Care Excellence [NICE] vs European Association of Urology [EAU]) and completed three case\u2010based real\u2010life scenarios derived from NMIBC cases with discordant risk stratification between NICE and EAU guidelines. Cases were randomly selected from a local database using a computer\u2010generated random number function in Microsoft Excel. Concordance between respondents' decisions and their stated guideline was assessed for risk stratification and surveillance duration.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 174 eligible responses were analysed. Most units (38%) followed NICE guidelines, but individual clinicians most frequently reported that they were following EAU guidelines (39%). Those who followed NICE guidelines demonstrated significantly higher compliance with the duration of follow\u2010up as recommended in the guidelines than did those who followed EAU guidelines (78.9% vs 49.2%,\n P<\/jats:italic>\n \u2009<\u20090.001). Deviations from the guidelines for those who followed NICE were predominantly in duration of surveillance, which was longer than recommended. Conversely, those following EAU guidelines frequently opted for shorter\u2010than\u2010recommended follow\u2010up (\n P<\/jats:italic>\n \u2009<\u20090.001). Consistent guideline\u2010based risk stratification was achieved in 77.1% of those following NICE guidelines and 34.1% of those following EAU guidelines (\n P<\/jats:italic>\n \u2009<\u20090.001). Acceptable recurrence risk at discharge did not differ between guideline groups (\n P<\/jats:italic>\n \u2009=\u20090.278).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Substantial variation exists in NMIBC guideline adherence and real\u2010world application in the UK. NICE guidance was associated with greater consistency and utility compared with EAU guidance for low\u2010 and intermediate\u2010risk disease. These findings highlight the need for clearer, unified recommendations to promote equitable care and rational use of surveillance resources.<\/jats:p>\n <\/jats:sec>","DOI":"10.1111\/bju.70354","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:52:52Z","timestamp":1781592772000},"page":"449-455","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adoption, consistency, and usability of\n NICE<\/scp>\n vs\n EAU<\/scp>\n guidelines in low\u2010 and intermediate\u2010risk\n NMIBC<\/scp>\n : a cross\u2010sectional survey of\n UK<\/scp>\n urologists"],"prefix":"10.1111","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0931-9707","authenticated-orcid":false,"given":"Youssef","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Urology Department Guy's Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Urology Department Guy's Hospital London UK"},{"name":"Urology Department St George's Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1153-5249","authenticated-orcid":false,"given":"Martina","family":"Spazzapan","sequence":"additional","affiliation":[{"name":"Urology Department Guy's Hospital London UK"},{"name":"King's College University London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Gad","sequence":"additional","affiliation":[{"name":"Urology Department Guy's Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9973-7368","authenticated-orcid":false,"given":"Findlay","family":"Macaskill","sequence":"additional","affiliation":[{"name":"Urology Department Guy's Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"O'Kelly","sequence":"additional","affiliation":[{"name":"Urology Department Guy's Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed Shamim","family":"Khan","sequence":"additional","affiliation":[{"name":"Urology Department Guy's Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Thurairaja","sequence":"additional","affiliation":[{"name":"Urology Department Guy's Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Nair","sequence":"additional","affiliation":[{"name":"Urology Department Guy's Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsie","family":"Mensah","sequence":"additional","affiliation":[{"name":"Urology Department Guy's Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin Abu","family":"Ghanem","sequence":"additional","affiliation":[{"name":"Urology Department Guy's Hospital London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.12.033"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-022-04253-3"},{"key":"e_1_2_10_4_1","volume-title":"WHO handbook for guideline development","author":"World Health Organization","year":"2014"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.3233\/BLC-150034"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2017.09.002"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.09.022"},{"key":"e_1_2_10_8_1","unstructured":"BLATUR NMIBC Navigator. Available at:https:\/\/blatur.com. Last accessed 22 April 2026"},{"key":"e_1_2_10_9_1","unstructured":"European Association of Urology NMIBC Risk Calculator. Available at:https:\/\/nmibc.net\/. Last accessed 22 April 2026"},{"key":"e_1_2_10_10_1","unstructured":"BabjukM BurgerM ComperatEMet\u00a0al.European Association of Urology Guidelines on Non\u2010muscle\u2010invasive Bladder Cancer (TaT1 and CIS): Predicting disease recurrence and progression (Section 6).EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid 2025."},{"key":"e_1_2_10_11_1","volume-title":"Bladder Cancer: Diagnosis and Management (NG2)","author":"National Institute for Health and Care Excellence (NICE)","year":"2015"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6304-y"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.735704"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.06.013"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2018-136184"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.70354","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bju.70354","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.70354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:01:38Z","timestamp":1786435298000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.70354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/bju.70354"],"URL":"https:\/\/doi.org\/10.1111\/bju.70354","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"2026-06-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}